HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Superiority of tc-99m MAG3 to tc-99m DTPA in treating a patient with mild renal artery stenosis.

Abstract
A 22-year-old female patient with severe hypertension underwent both Technetium-99m diethylenetriaminepentaacetate and Technetium-99m mercaptoacetyltriglycine basal and captopril renal scintigraphy. While no significant change was seen with Tc-99m DTPA, there was left sided parenchymal retention of captopril Tc-99m MAG3 suggesting renal artery stenosis which was confirmed by angiography.
AuthorsP O Kiratli, B Caner, B Altun, S Cekirge
JournalAnnals of nuclear medicine (Ann Nucl Med) Vol. 15 Issue 1 Pg. 45-8 (Feb 2001) ISSN: 0914-7187 [Print] Japan
PMID11355781 (Publication Type: Case Reports, Comparative Study, Journal Article)
Chemical References
  • Radiopharmaceuticals
  • Technetium Tc 99m Mertiatide
  • Captopril
  • Technetium Tc 99m Pentetate
Topics
  • Adult
  • Angiography
  • Blood Pressure (drug effects)
  • Captopril
  • Female
  • Humans
  • Hypertension, Renovascular (etiology)
  • Kidney (diagnostic imaging)
  • Radionuclide Imaging
  • Radiopharmaceuticals (pharmacokinetics)
  • Renal Artery Obstruction (diagnostic imaging)
  • Technetium Tc 99m Mertiatide (pharmacokinetics)
  • Technetium Tc 99m Pentetate (pharmacokinetics)
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: